Cargando…
Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab
With the increasing number of indications for checkpoint inhibitor therapy in cancer patients, rheumatology specialists are often involved in the diagnosis and management of immune-related adverse events (irAEs). The most common rheumatic irAEs are arthritis, sicca syndrome, polymyalgia rheumatica,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802204/ https://www.ncbi.nlm.nih.gov/pubmed/35128334 http://dx.doi.org/10.31138/mjr.32.4.376 |